NO306197B1 - Anvendelse av 4-amino-1-hydroksybutyliden-1, 1-bis-fosfonsyre - Google Patents

Anvendelse av 4-amino-1-hydroksybutyliden-1, 1-bis-fosfonsyre

Info

Publication number
NO306197B1
NO306197B1 NO942267A NO942267A NO306197B1 NO 306197 B1 NO306197 B1 NO 306197B1 NO 942267 A NO942267 A NO 942267A NO 942267 A NO942267 A NO 942267A NO 306197 B1 NO306197 B1 NO 306197B1
Authority
NO
Norway
Prior art keywords
hydroxybutylidene
amino
bis
phosphonic acid
periodontal disease
Prior art date
Application number
NO942267A
Other languages
English (en)
Other versions
NO942267D0 (no
NO942267L (no
Inventor
Barry J Gertz
Gideon A Rodan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO942267D0 publication Critical patent/NO942267D0/no
Publication of NO942267L publication Critical patent/NO942267L/no
Publication of NO306197B1 publication Critical patent/NO306197B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
NO942267A 1991-12-17 1994-06-16 Anvendelse av 4-amino-1-hydroksybutyliden-1, 1-bis-fosfonsyre NO306197B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/808,701 US5270365A (en) 1991-12-17 1991-12-17 Prevention and treatment of periodontal disease with alendronate
PCT/US1992/010534 WO1993011774A1 (en) 1991-12-17 1992-12-08 Treatment of periodontal disease with alendronate

Publications (3)

Publication Number Publication Date
NO942267D0 NO942267D0 (no) 1994-06-16
NO942267L NO942267L (no) 1994-06-16
NO306197B1 true NO306197B1 (no) 1999-10-04

Family

ID=25199466

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942267A NO306197B1 (no) 1991-12-17 1994-06-16 Anvendelse av 4-amino-1-hydroksybutyliden-1, 1-bis-fosfonsyre

Country Status (22)

Country Link
US (1) US5270365A (no)
EP (1) EP0617624B1 (no)
JP (1) JP2825654B2 (no)
KR (1) KR100258667B1 (no)
AT (1) ATE150646T1 (no)
AU (1) AU675417B2 (no)
CA (1) CA2122498A1 (no)
CY (1) CY2054B1 (no)
CZ (1) CZ282902B6 (no)
DE (1) DE69218624T2 (no)
DK (1) DK0617624T3 (no)
ES (1) ES2100519T3 (no)
GR (1) GR3022951T3 (no)
HK (1) HK1000114A1 (no)
HU (1) HU221807B1 (no)
IL (1) IL104109A (no)
LV (1) LV12084B (no)
NO (1) NO306197B1 (no)
NZ (1) NZ246274A (no)
SK (1) SK280628B6 (no)
WO (1) WO1993011774A1 (no)
ZA (1) ZA929712B (no)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW237386B (no) * 1992-04-15 1995-01-01 Ciba Geigy
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US5854227A (en) * 1994-03-04 1998-12-29 Hartmann; John F. Therapeutic derivatives of diphosphonates
WO1995028145A1 (en) * 1994-04-18 1995-10-26 The Procter & Gamble Company Iontophoretic delivery of bisphosphonates to the alveolar bone
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
US6008206A (en) * 1994-09-21 1999-12-28 Merck & Co., Inc. Sodium alendronate preparation for local administration
JP3411690B2 (ja) * 1994-09-21 2003-06-03 帝人株式会社 局所投与用アレンドロン酸ナトリウム製剤
AU690431B2 (en) * 1995-02-17 1998-04-23 Merck & Co., Inc. Method of lessening the risk of non-vertebral bone fractures
AU713824B2 (en) * 1995-05-12 1999-12-09 Merck Sharp & Dohme Corp. Prevention of tooth loss by the administration of alendronate or its salts
US6117856A (en) * 1996-02-14 2000-09-12 Binderman; Itzhak Topical bisphosphonates for prevention of bone resorption
ES2197329T3 (es) * 1996-02-14 2004-01-01 Itzhak Binderman Bisfosfonatos topicos para la prevencion de la reabsorcion osea.
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
WO1997044017A1 (en) * 1996-05-17 1997-11-27 Merck & Co., Inc. Effervescent bisphosphonate formulation
EP1378234A1 (en) * 1996-05-17 2004-01-07 MERCK & CO. INC. Effervescent bisphosphonate formulation
EA001213B1 (ru) * 1996-10-04 2000-12-25 Мерк Энд Ко., Инк. Композиции жидкого алендроната
US5773429A (en) * 1996-12-11 1998-06-30 Fuisz Technologies Ltd. Drug combination for treating calcium loss
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
PT998292E (pt) * 1997-07-22 2002-04-29 Merck & Co Inc Metodo para inibicao da reabsorcao ossea
US5994329A (en) * 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
FR2784031B1 (fr) * 1998-10-02 2002-02-01 Sanofi Elf Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries
US6331533B1 (en) * 1998-11-16 2001-12-18 Merck & Co., Inc. Method for inhibiting dental resorptive lesions
CA2356262A1 (en) * 1998-12-23 2000-07-06 Jomaa Pharmaka Gmbh Use of bisphosphonates for the prevention and treatment of infectious processes
US6315566B1 (en) 1999-05-18 2001-11-13 3M Innovative Properties Company Dental materials
US6143919A (en) * 1999-05-18 2000-11-07 3M Innovative Properties Company Polymerizable acidic compounds and methods of preparation
PL196485B1 (pl) * 2000-05-11 2008-01-31 Inst Farmaceutyczny Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
US20030216358A1 (en) * 2001-07-05 2003-11-20 Muchmore Douglas Boyer Method for enhancing bone mineral density gain
US20040053968A1 (en) * 2001-12-28 2004-03-18 Hartman George D. Methods and compositions for treating peridontal disease
US20070094865A1 (en) * 2002-01-10 2007-05-03 Ji-Guang Zhang Packaged thin film batteries and methods of packaging thin film batteries
US7960054B2 (en) * 2002-01-10 2011-06-14 Excellatron Solid State Llc Packaged thin film batteries
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
US20030195171A1 (en) * 2002-04-05 2003-10-16 Daifotis Anastasia G. Method for inhibiting bone resorption with an alendronate and vitamin D formulation
FR2838339B1 (fr) * 2002-04-12 2005-06-24 Univ Angers Derives poly-phosphonates pour compositions dentifrices
US20040137058A1 (en) * 2002-07-09 2004-07-15 Katdare Ashok V. Effervescent bisphosphonate formulation
US20050142185A1 (en) * 2003-12-29 2005-06-30 Beleno Alfredo B. Softgel formulations of bisphosphonates bone resorption inhibitors
US20060034921A1 (en) * 2004-01-05 2006-02-16 Katdare Ashok V Effervescent bisphosphonate formulation
US20050181043A1 (en) * 2004-02-12 2005-08-18 Indranil Nandi Alendronate salt tablet compositions
US20080070087A1 (en) * 2004-02-20 2008-03-20 Excellatron Solid State, Llc Non-volatile cathodes for lithium oxygen batteries and method of producing same
US20050261250A1 (en) * 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
KR100564628B1 (ko) * 2004-06-16 2006-03-28 삼성전자주식회사 스플릿 게이트형 플래쉬 메모리 소자 및 그 제조방법
US20060134190A1 (en) * 2004-12-16 2006-06-22 Banner Pharmacaps Inc. Formulations of bisphosphonate drugs with improved bioavailability
CN101351907B (zh) * 2005-10-11 2010-09-29 埃克塞勒特龙固体公司 制造锂电池的方法
US20070087052A1 (en) * 2005-10-19 2007-04-19 Katdare Ashok V Effervescent bisphosphonate formulation
KR20080106574A (ko) 2006-03-10 2008-12-08 엑셀라트론 솔리드 스테이트 엘엘씨 에어 배터리 및 에어 배터리 제작 방법
US20090118238A1 (en) * 2007-09-17 2009-05-07 Protia, Llc Deuterium-enriched alendronate
WO2011017253A1 (en) 2009-08-03 2011-02-10 Chimerix, Inc. Composition and methods of treating viral infections and viral induced tumors
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
RU2449761C1 (ru) * 2011-03-09 2012-05-10 Светлана Минифаритовна Алетдинова Способ лечения хронических апикальных периодонтитов
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
US9579360B2 (en) 2012-06-20 2017-02-28 The Trustees Of The University Of Pennsylvania Methods of treating or preventing periodontitis and diseases associated with periodontitis
RU2713257C1 (ru) * 2019-05-06 2020-02-04 Жанна Владимировна Вечеркина Способ лечения хронического апикального периодонтита

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429963A (en) * 1964-06-09 1969-02-25 Colgate Palmolive Co Dental preparation containing polymeric polyelectrolyte
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4134969A (en) * 1974-02-04 1979-01-16 Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) Method of treatment of calcium disorders using aminoalkane-diphosphonic acids
US4042679A (en) * 1975-11-07 1977-08-16 Colgate-Palmolive Company Antibacterial oral composition
US4138477A (en) * 1976-05-28 1979-02-06 Colgate Palmolive Company Composition to control mouth odor
US4440779A (en) * 1981-06-30 1984-04-03 Merck & Co., Inc. Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4677132A (en) * 1986-03-12 1987-06-30 American Home Products Corporation Inhibition of bone resorption by etodolac
IL84493A (en) * 1986-11-21 1993-01-14 Ciba Geigy Ag Aromatically substituted azacycloalkylalk - anediphosphonic acids, their preparation and pharmaceutical compositions containing them
ES2038693T3 (es) * 1986-11-21 1993-08-01 Ciba-Geigy Ag Nuevos acidos aminometanodifosfonicos substituidos.
US4973576A (en) * 1987-03-10 1990-11-27 Yamanouchi Pharmaceutical Co., Ltd. Bisphophonic acid derivatives and pharmaceutical compositions containing the same
US4816437A (en) * 1987-06-01 1989-03-28 Trustees Of Boston University Methods for inducing general and localized bone apposition in-vivo
EP0317505A1 (de) * 1987-11-13 1989-05-24 Ciba-Geigy Ag Neue Azacycloalkylalkandiphosphonsäuren
GB8726714D0 (en) * 1987-11-14 1987-12-16 Beecham Group Plc Compounds
ES2054868T3 (es) * 1987-12-11 1994-08-16 Ciba Geigy Ag Acidos aralifatilaminoalcanodifosfonicos.
US4877603A (en) * 1987-12-18 1989-10-31 The Procter & Gamble Company Oral compositions
DE3822650A1 (de) * 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4990503A (en) * 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives
CA2035179C (en) * 1990-01-31 2001-08-14 Gerald S. Brenner Pharmaceutical compositions containing insoluble salts of bisphosphonic acids
GB9008433D0 (en) * 1990-04-12 1990-06-13 Beecham Group Plc Novel compositions
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof

Also Published As

Publication number Publication date
NO942267D0 (no) 1994-06-16
ZA929712B (en) 1993-06-14
EP0617624B1 (en) 1997-03-26
SK72794A3 (en) 1995-04-12
JPH07502506A (ja) 1995-03-16
HK1000114A1 (en) 1997-12-05
GR3022951T3 (en) 1997-06-30
JP2825654B2 (ja) 1998-11-18
HU221807B1 (hu) 2003-01-28
SK280628B6 (sk) 2000-05-16
NZ246274A (en) 1997-02-24
ES2100519T3 (es) 1997-06-16
NO942267L (no) 1994-06-16
DE69218624T2 (de) 1997-08-07
AU3242093A (en) 1993-07-19
LV12084B (en) 1998-11-20
AU675417B2 (en) 1997-02-06
LV12084A (lv) 1998-07-20
KR100258667B1 (ko) 2000-07-01
CA2122498A1 (en) 1993-06-24
IL104109A (en) 1997-02-18
CZ148794A3 (en) 1995-03-15
DE69218624D1 (de) 1997-04-30
ATE150646T1 (de) 1997-04-15
CY2054B1 (en) 1998-04-30
IL104109A0 (en) 1993-05-13
EP0617624A1 (en) 1994-10-05
DK0617624T3 (da) 1997-04-21
US5270365A (en) 1993-12-14
HU9401378D0 (en) 1994-08-29
WO1993011774A1 (en) 1993-06-24
KR940703676A (ko) 1994-12-12
HUT68788A (en) 1995-07-28
CZ282902B6 (cs) 1997-11-12

Similar Documents

Publication Publication Date Title
NO306197B1 (no) Anvendelse av 4-amino-1-hydroksybutyliden-1, 1-bis-fosfonsyre
ES2169046T3 (es) Analogo de prostaglandina para el tratamiento de la osteoporosis.
NO952890L (no) Kombinasjonsbehandling for inhibisjon av bentap
RU93054537A (ru) Производные гуанидиналкил-1,1-бисфосфоновой кислоты, способ их получения и их применение
SE8704248D0 (sv) Medical use
ATE129155T1 (de) Verwendung von phosphatidylglycerol(dic 18:10) zur behandlung obstruktiver atemwegserkrankungen.
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
IL133172A (en) Diphosphonic acid salts for the treatment of osteoporosis
EE9600191A (et) Püridüülbisfosfonaatide kasutamine terapeutiliste toimeainetena
ATE135681T1 (de) Diclofenac-cholinsalz, verfahren zur herstellung und pharmazeutische zusammensetzungen, die es enthalten
KR970705400A (ko) 골 활성 포스포네이트 및 부갑상선 호르몬을 사용한 골다공증의 치료방법(methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone)
HUT48464A (en) Process for producing pharmaceutical composition for treating hypertonia and cardiac failure
FI923662A (fi) Terapeutiska medel
DE69320187D1 (de) Phosphono suphonate verbindungen zur behandlung abnormalen kalzium- und phospat- metabolismuses
DK0612246T3 (da) Farmaceutiske sammensætninger af galliumkomplekser med 3-hydroxy-4-pyroner
AR011178A1 (es) Compuesto de sal de sodio de (acido (e) 4,6-dicloro-3-(2-oxo-1- fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico en su forma hidratada,proceso para su preparacion, composicion farmaceutica que lo contiene y metodo de tratamiento utilizando dicho compuesto
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
TR199700921T1 (xx) �nsanlarda g�r�len herpes-vir�s-8'in tedavisinde pensiklovir'in kullan�lmas�.
IT1245631B (it) Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina